×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
IQWiG-Berichte – Nr. 684 Nivolumab (Melanom)€¦ · IQWiG-Berichte – Nr. 684 Nivolumab (Melanom) – Nutzenbewertung gemäß § 35a SGB V . Dossierbewertung A18-53 Version 1.0
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form